Introduction
Polycystic ovary syndrome (PCOS), characterized by hyperandrogenism, chronic anovulation and oligo-ovulation, affects an estimated 7.4% of women of reproductive age in China (1) (2) (3) . The pathogenesis of PCOS remains unknown, but there are increasing implications for a strong genetic basis (4, 5) . Familial aggregation of hyperandrogenic symptoms (hirsutism and oligomenorrhea) was found in a series of family-based studies in patients presenting with hyperandrogenism or PCOS (6) . Hyperandrogenism is regarded as one of the causal factors of PCOS, and common variants of androgen-related genes may influence the activity of androgen. Androgen exerts its action primarily through the androgen receptor (AR), a liganddependent nuclear transcription factor. In vitro studies suggest that androgen promotes the development of follicles (7, 8) , which is mainly governed by ARs via the upregulation of genes encoding follicle-stimulating hormone receptor, insulin-like growth factor (IGF-1) and IGF-1 receptor (9, 10) . Numerous studies have concentrated on a various number tandem repeat (VNTR) polymorphism consisting of CAG repeats [(CAG) n ] in exon 1 of the AR gene located at Xq11-12. The (CAG) n encodes for a polyglutamine tract located in the transactivation domain of AR. Early studies suggest that the number of CAG repeats is inversely related to AR activity (11); thus a shorter CAG track is more common in patients with ovarian hyperandrogenism (11, 12) and hirsutism (12) . Higher activity of AR induces the development of follicles, and thus may cause the formation of PCOS; meanwhile, AR hyperactivity may explain some of the PCOS patients exhibiting normal serum androgen levels but hyperandrogenism symptoms (13) . In this study, we hypothesized that shorter CAG tracks are associated with PCOS, and designed a case-control study to confirm. . After a 12-h overnight fast, all venous blood samples were obtained between 8 and 9 a.m. For those who had menstruation, the sample-collecting time was further restricted to the 3rd-5th day of the menstrual cycle. Estradiol (E2), testosterone (T), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) levels in the sera were detected by radioimmunoassay (RIA, Beijing North Institute of Biological Technology of China and the CIS Company of France). All assays had intra-and inter-assay coefficients of variation <10%.
Materials and methods

Subjects
Genotyping of the (CAG) n . Genomic DNA was extracted from blood using the SBS UltraPure™ Genome DNA kit (SBS Genetech, Shanghai, China) according to the manufacturer's instructions. PCR was carried out in a total volume of 25 µl consisting of 50 ng DNA, 7.5 pmol of each primer, 2.5 µl STR (short tandem repeat) 10X buffer (Promega, Madison, WI, USA) and 0.75 unit of GoTaqDNA polymerase (Promega). The forward primer was 5'-ACC GAG GAG CTT TCC AGA AT-3', the reverse primer was 5'-CTC ATC CAG GAC CAG GTA GC-3' and labeled at the 5' with 6-FAM, a laser-activated fluorescent dye. All PCR reactions were performed with a MultiGene Gradient Thermal Cycler (Labnet, Edison, NJ, USA) under the following conditions: an initial denaturating step at 96˚C for 2 min, followed by 10 cycles of denaturation at 94˚C for 1 min, annealing at 60˚C for 1 min and extension at 70˚C for 1.5 min, followed by another 25 cycles of denaturation at 90˚C for 1 min, annealing at 60˚C for 1 min and extension at 70˚C for 1.5 min, and a final extension at 72˚C for 30 min. PCR products were then 5-fold diluted with deionized water, and 1 µl was mixed with 8.7 µl HI-DI formamide and 0.3 µl Genescan-500 (LIZ) (Applied Biosystems, Warrington, UK). After denaturing at 95˚C for 5 min, each sample was analyzed by capillary electrophoresis on an ABI 3130 Genetic Analyzer (Applied Biosystems). The results were analyzed in GeneMapper version 3.7 (Applied Biosystems) (Fig. 1) , and PCR product sizes were exported and used for calculating the repeat number of CAG in the AR gene. Finally, a subset was directly sequenced to confirm the exact repeat size.
Setting categories. We divided AR (CAG) n into different categories according to CAG repeat number. By setting 20, the mean CAG repeat of controls, as the cut-off value, we obtained three alleles, <20 (short allele), 20 (mean allele) and >20 (long allele), represented by the letter 'S' 'M' 'L', respectively. To further analyze the CAG distribution in the PCOS population, we divided PCOS women into 'obese case' and 'lean case' categories by taking BMI 23 as the borderline (16), different from the World Health Organization (WHO) criteria.
Statistical methods. The results of serum hormone levels, age, BMI are reported as means ± SD. The two-sample independent t-test was used to compare clinical and biochemical characteristics between the women with PCOS and controls. The CAG allelic distributions between PCOS and controls were compared by χ 2 test. Genotypic distribution among three newly formed alleles (S, M and L) was analyzed by using Fisher's exact test. Biochemical steroid levels among different genotypes were tested by analysis of covariance (ANCOVA) to correct for age and BMI. P<0.05 was considered statistically significant. All statistic analyses were performed using SPSS version 17.0 (SPSS Inc., Chicago, IL, USA).
Results
Clinical and endocrine characteristics. Clinical and endocrine characteristics of the PCOS patients were consistent with Rotterdam criteria (Table I) (Fig. 1) .
Distribution of CAG alleles in the samples. Androgen receptor CAG repeats ranged from 12-28 in PCOS cases and 12-32 in the controls (Fig. 2) . In addition, few extremely short alleles were detected in our study, with one (CAG) 6 allele noted in PCOS patient, one (CAG) 9 allele and three (CAG) 10 alleles in the control group; no homozygous genotype of these alleles was observed (Fig. 2) .
Distribution of cases and controls via qualitative categories of CAG repeats.
The newly formed S-M-L allelic distribution was significantly different between the PCOS group and controls (P=0.007) (Table II) , exhibiting a higher frequency of the 'S' allele and a lower frequency of the 'L' allele in the PCOS group. Similarly, CAG biallelic mean distributions also showed significant statistical difference between the two groups (P=0.025) (Table II) .
Clinical and endocrine characteristics among different categories of samples.
Clinical and biochemical hormone levels of the three 'alleles' are shown in Table III , no statistical difference was found both in PCOS patients and controls.
Mean CAG biallelic distribution among lean and obese PCOS cases. When the PCOS group was divided into lean cases and obese cases, no significant difference was found in terms of allelic distribution (P=0.244) (Table IV) .
Discussion
In this study, we found a strong association between a shorter AR-CAG repeat length and a higher presence of PCOS, providing a convincing evidence for the role AR (CAG) n plays in the pathogenesis of PCOS in Han Chinese women. This result indicates that short CAG allele repeats may be a potential risk for PCOS. Our results were consistent with previous functional studies demonstrating that a short CAG repeat resulted in high intrinsic activity of AR (17) (18) (19) . Ibanez et al (20) found that the serum testosterone level was markedly reduced after adminstration of flutamide, an inhibitor of AR. Therefore, we inferred that increased AR activity enhances ovarian androgen production, resulting in a high level of testosterone in PCOS women. Similarly, other studies strongly support the hypothesis that PCOS phenotypes may result from enhanced sensitivity to androgens caused by a more active AR (21) (22) (23) . The most striking evidence demonstrating AR (CAG) n as a leading causal factor of ovarian hyperandrogenism was demonstrated in a follow-up study on Spanish girls. Ibanez et al found that girls with premature pubarche and subsequent ovarian hyperandrogenism exhibited a shorter AR (CAG) n repeat length compared with healthy controls (12), while another investigator insisted that shorter CAG repeats heighten androgen levels only when combined with longer alleles of SHBG (TAAAA) n pentanucleotide polymorphism (24) .
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On the contrary, other studies yielded divergent or even extremely opposing results. While most studies revealed no difference in the distribution of allelic frequencies or biallelic mean between PCOS cases and controls (23, (25) (26) (27) , Hickey et al (22) demonstrated that longer alleles were more common in PCOS patients. However, additional studies suggest that the AR (CAG) n polymorphism may be a modulator of androgenmediated phenotypes in certain individuals instead of a determinant factor of PCOS (28) .
Several interacting factors may account for the discrepancies among studies. The first and most significant reason is due to the ethnic composition. The AR (CAG) n allele frequencies were different. Ackerman et al (29) revealed that potential ethnic differences might exist in androgenic pathway activity and androgen sensitivity after a large-sample study in four ethnic populations (29) . Secondly, patients chosen were also different: ⅰ) a globally accepted diagnostic scheme for PCOS is not available. The 2003 Rotterdam criteria was used in this study, while other definitions of PCOS were also applied in other studies (21, 22, 28) . ⅱ) Different diseases with symptoms of hyperandrogenism were also studied, i.e. PCOS and precocious pubarche, and other factors specifically affecting one particular disease may affect the outcome of studies. Thirdly, lack of a large enough sample size could, to a certain extent, make some studies less credible.
In summary, short AR (CAG) n variants may be a potential risk factor for PCOS. More systematic studies with large sample sizes are needed in the future to clarify the possible mechanisms involved. Table IV . Qualitative distribution of the CAG biallelic mean among lean and obese PCOS cases. Table III . Anthropometric characteristics and serum hormone concentrations of PCOS cases and controls according to the qualitative categories of the x-CAG biallelic mean. 
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